Skip to main content
SpringerLink
Log in

Le cancer canalaire in situ en 2011. Synthèse des nouvelles données de la littérature et des recommandations INCa-SFSPM

  • Conference paper
Cancer du sein

  • 539 Accesses

Résumé

Cet article fait une synthèse des connaissances actuelles sur le carcinome canalaire in situ (CCIS) après la publication en octobre 2009 des recommandations élaborées à la suite du partenariat entre l’Institut National du Cancer et la Société française de sénologie de pathologie mammaire (www.e-cancer.fr) et la publication en octobre 2010 de la monographie du National Cancer Institute (NCI) sur le même sujet (avec en particulier les données de la méta-analyse de l’EBCTCG). Il intègre également de nombreuses références très récentes traitant de multiples aspects de cette pathologie ainsi que des données complémentaires de l’Observatoire national PRACCIS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Allred DC (2010) Ductal carcinoma in situ: terminology, classification and natural history. J Natl Cancer Inst Monog 41: 134–138

    Article  Google Scholar 

  2. Silverstein MJ, Lagios MD, Martino S et al. (1998) Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 16: 1367–1373

    PubMed  CAS  Google Scholar 

  3. Marty M, Rossignol C, Serruys C et al. (1992) Le cancer du sein au moment du diagnostic. Etude nationale de la CANAM: analyse de 3007 cas. Press Med 21: 1017–1021

    CAS  Google Scholar 

  4. Groupe de Travail INCA-SFSPM. Recommandations pour la pratique clinique. Cancer in situ. www.e-cancer.fr

    Google Scholar 

  5. Virnig BA, Tuttle TM, Shamliyant T, Kane PL (2010) Ductal Carcinoma in situ of the breast: a systemic review of incidence, treatment and outcomes. J Natl Cancer Inst 102: 170–178

    Article  PubMed  Google Scholar 

  6. Cutuli B, Lemanski C, Fourquet A et al. (2010) Carcinomes canalaires in situ (CCIS) caractéristiques histopathologiques et traitement: analyse de 1289 cas. Bull Cancer 97: 301–310

    PubMed  CAS  Google Scholar 

  7. Kerlikowske K, Molinaro AM, Gauthier ML et al. (2010) Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102: 627–637

    Article  PubMed  CAS  Google Scholar 

  8. Claus EB, Stowe M, Carter D (2001) Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93: 1811–1817

    Article  PubMed  CAS  Google Scholar 

  9. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for Ductal Carcinoma in situ of the breast. JAMA 275: 913–918

    Article  PubMed  CAS  Google Scholar 

  10. Reeves GK, Beral V, Green J et al. (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analyses. Lancet Oncol 7: 910–918

    Article  PubMed  CAS  Google Scholar 

  11. Claus EB, Petruzella S, Matloff E, Carter D (2005) Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 293: 964–969

    Article  PubMed  CAS  Google Scholar 

  12. Cutuli B, Lemanski C, Fourquet A et al. (2009) French National Survey on DCIS: analysis of clinico-pathological features and treatments in 1289 patients. Br J Cancer 100: 1048–1054

    Article  PubMed  CAS  Google Scholar 

  13. Barreau B, De Mascarel I, Feuga C et al. (2005) Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol 54: 55–61

    Article  PubMed  Google Scholar 

  14. Cutuli B, Fourquet A, Luporsi E et al. (2004) Standards, Options et Recommandations 2004. Prise en charge des carcinomes canalaires in situ du sein. www.fnclcc.fr

    Google Scholar 

  15. Kuhl CK, Schrading S, Bicling HB et al. (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370: 485–492

    Article  PubMed  Google Scholar 

  16. Lehman CD (2010) Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monog 41: 150–151

    Article  Google Scholar 

  17. Lourenco AP, Mainiero MB, Lazarus E, Giri D, Schepps B (2007) Stereotactic breast biopsy: comparison of histologic underestimation rates with 11-and 9-gange vacuum-assisted breast biopsy. Am J Roentgenol 189: W 275–279

    Article  Google Scholar 

  18. Darling ML, Smith DN, Lester EC et al. (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-care needle biopsy: results of surgical excision. Am J Roentgenol 175: 1341–1346

    CAS  Google Scholar 

  19. Eby PR, Ochsner JE, De Martini WB et al. (2009) Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy 9-versus 11-gange. Am J Roentgenol 192: 229–234

    Article  Google Scholar 

  20. Schwartz GF, Solin LJ, Olivotto IA et al. (2000) Consensus Conference on the treatment of in situ Ductal Carcinoma of the breast. Cancer 88: 946–954

    Article  PubMed  CAS  Google Scholar 

  21. Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of Ductal Carcinoma In situ. A meta-analysis. Cancer 85: 616–628

    Article  PubMed  CAS  Google Scholar 

  22. Guerrieri-Gonzaga A, Botteri E, Rotmensz N et al. (2009) Ductal intraepithelial neoplasia: post surgical outcome of 1267 women cared for in one single institution over 10 years. The Oncologist 14: 201–212

    Article  PubMed  Google Scholar 

  23. Rakovitch E, Pignol JP, Chartier C et al. (2007) The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat 3: 335–347

    Article  Google Scholar 

  24. Cutuli B, Cohen Solal Le Nir C, De Lafontan B et al. (2001) Ductal Carcinoma in situ of the breast. Results of conservative and radical treatments in 716 patients. Eur J Cancer 37: 2365–2372

    Article  PubMed  CAS  Google Scholar 

  25. Smith GL, Smith BD, Haffty BG (2006) Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 5: 1397–1403

    Article  Google Scholar 

  26. Katz SJ, Lantz PM, Janz NK et al. (2005) Patterns and correlates of local therapy for women with ductal carcinoma in situ. J Clin Oncol 23: 3001–3007

    Article  PubMed  Google Scholar 

  27. Silverstein MJ (2002) The Van Nuys/USC Experience by treatment. In: Silverstein MJ, Recht A, Lagios M, eds. Ductal Carcinoma in situ of the breast. 2d ed. Philadelphia: Lippincott William & Wilkins; 337–342

    Google Scholar 

  28. Tunon De Lara C, De Mascarel I, MacGrogan G et al. (2001) Analysis of 676 ductal carcinoma in situ (DCIS) of the breast from 1971 to 1995: diagnosis and treatment; the experience of one institute. Am J Clin Oncol 24: 531–536

    Article  PubMed  CAS  Google Scholar 

  29. Idvall I, Anderson H, Ringberg A, Ferno A (2003) Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast? Eur J Cancer 39: 1704–1710

    Article  PubMed  CAS  Google Scholar 

  30. Schouten Van Der Velden AP, Vab Vugt R, Van Duck JA, Leer JW, Wobbes T (2007) Local recurrences after different treatement strategies for ductal carcinoma in situ of the breast: a population-based study in the east Netherlands. Int J Radiat Oncol Biol Phys 69: 703–710

    Article  PubMed  Google Scholar 

  31. Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJT (2008) Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 15: 235–243

    Article  PubMed  Google Scholar 

  32. Thomas J, Evans A, MacCartney J et al. (2010) Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project. Br J Cancer 102: 285–283

    Article  PubMed  CAS  Google Scholar 

  33. Elmore JG, Ganshow PS, Geller BM (2010) Communication between patients and providers and informed decision making. J Nath Cancer Inst Monog 41: 201–209

    Google Scholar 

  34. Baxter N, Virnig BA, Durham JB, Tuttle TM (2004) Trend in treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96: 443–448

    Article  PubMed  Google Scholar 

  35. Sumner WE, Koniaris LG, Snell SE et al. (2007) Results of 23 810 cases of ductal carcinoma in situ. Ann Surg Oncol 14: 1638–1643

    Article  PubMed  Google Scholar 

  36. Thomas J, Evans A, MacCartney J et al. (2010) Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project. Br J Cancer 102: 285–293

    Article  PubMed  CAS  Google Scholar 

  37. Cunning GH, Mokbel K (2006) Oncological considerations of skin-sparing mastectomy. Int Semin Surg Oncol 25: 3–14

    Google Scholar 

  38. Lagios MD (2002) The Lagios experience. In: Silverstein MJ, Recht A, Lagios M, eds. Ductal Carcinoma in situ of the breast. 2d ed. Philadelphia; Lippincott William & Wilkins: 303–307

    Google Scholar 

  39. Schwartz GF (1997) Treatment of subclinical ductal carcinoma in situ by local excision and surveillance: a personal experience. In: Silverstein MJ, ed. Ductal Carcinoma in situ of the breast. Baltimore; Williams & Wilkins: 353–360

    Google Scholar 

  40. Hughes LL, Wang M, Page DL et al. (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27: 5319–5324

    Article  PubMed  Google Scholar 

  41. Mokbel K, Cutuli B (2006) Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol 7: 756–765

    Article  PubMed  Google Scholar 

  42. Kane RL, Virnig BA, Shamliyan T et al. (2010) The impact of surgery, radiation and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monog 41: 130–133

    Article  Google Scholar 

  43. Solin L (2010) The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monog 41: 187–192

    Article  Google Scholar 

  44. Cutuli B, Cohen Solal Le Nir C, De Lafontan B et al. (2002) Breast conserving therapy for ductal carcinoma in situ of the breast: the French Cancer centers’ experience. Int J Radiat Oncol Biol Phys 53: 868–879

    Article  PubMed  Google Scholar 

  45. Solin L, Fourquet A, Vicini F et al. (2005) Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 1003: 1137–1146

    Article  Google Scholar 

  46. Vargas C, Kestin L, Go N et al. (2005) Factors associated with local recurrence and cause specific survival in patients with ductal carcinoma in situ of the breast treated with brest-conserving therapy or mastectomy. Int J Rad Oncol Biol Phys 63: 1514–1521

    Article  Google Scholar 

  47. Ben-David MA, Sturtz DE, Griffith KA et al. (2007) Long-term results of conservation surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the university of Michigan experience. Breast J 13: 392–400

    Article  PubMed  Google Scholar 

  48. Morrow M, Strom E, Basset LW et al. (2002) Standard for the management of ductal carcinoma in situ of the breast. Cancer J Clin 52: 256–276

    Article  Google Scholar 

  49. Porembka MR, Abraham RL, Sefko JA et al. (2008) Factors associates with lymph node assessment in ductal carcinoma in situ: analysis of 1989-2002 SEER Data. et al. Ann Surg Oncol 15: 2709–2719

    Article  PubMed  Google Scholar 

  50. Yi M, Krishnamurthy S, Kuerer HM et al. (2008) Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196: 81–87

    Article  PubMed  Google Scholar 

  51. Zavagno G, Carcoforo P, Marconato R (2005) Role of axillary sentinel lymph node biopsy in patient with pure ductal carcinoma in situ of breast. BMC Cancer 5: 28

    Article  PubMed  Google Scholar 

  52. Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P (2009) The role of sentinel nod biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol 35: 43–47

    Article  PubMed  CAS  Google Scholar 

  53. Wilkie C, White L, Dupont E, Cantor A, Cox C (2005) An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190: 563–566

    Article  PubMed  Google Scholar 

  54. Julian TB, Land SR, Fourchotte V et al. (2007) Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol 14: 2202–2208

    Article  PubMed  Google Scholar 

  55. Intra M, Rotmensz N, Veronesi P et al. (2008) Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of European Institute of Oncology on 854 patients in 10-years. Ann Surg 247: 315–319

    Article  PubMed  Google Scholar 

  56. Sakr R, Barranger E, Antoine M et al. (2006) Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol 94: 426–430

    Article  PubMed  Google Scholar 

  57. Goyal A, Douglas-Jones A, Monypenny I et al. (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat 98: 311–314

    Article  PubMed  Google Scholar 

  58. Shapiro-Wrigt HM, Julian TB (2010) Sentinel node biopsy and management of axilla in ductal carcinoma in situ. J Natl Cancer Inst Monog 41: 145–149

    Article  Google Scholar 

  59. Fisher B, Costantino J, Redmond C et al. (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328: 1581–1586

    Article  PubMed  CAS  Google Scholar 

  60. Fisher B, Land S, Mamounas E et al. (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel project experience. Semin Oncol 28: 400–418

    Article  PubMed  CAS  Google Scholar 

  61. Bijker N, Peterse JL, Duchateau L et al. (2001) Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organisation for Research and Treatment of Cancer trial 10853. J Clin Oncol 19: 2263–2271

    PubMed  CAS  Google Scholar 

  62. Bijker N, Meijnen PH, Peterse JL et al. (2006) Breast conserving treatment with our without radiotherapy in breast conserving treatment for ductal carcinoma in situ (DCIS): Ten year results of European Organization for research and Treatment of Cancer (EORTC) randomized trial 10853. J Clin Oncol 24: 3381–3387

    Article  PubMed  Google Scholar 

  63. UK Coordinating committee on Cancer Research (UKCCCR) (2003) Ductal Carcinoma in situ Working Party Radiotherapy and Tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362: 95–102

    Google Scholar 

  64. Pinder SE, Duggan C, Ellis IO et al. (2010) A new pathological system for grading DCIS with improved prediction of local recurrence results from the UKCCLR/ANZ DCIS Trial. Br J Cancer 103: 94–100

    Article  PubMed  CAS  Google Scholar 

  65. Emdin S, Granstrand B, Ringberg A et al. (2006) SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammographic screening. Acta Oncologica 45: 536–543

    Article  PubMed  Google Scholar 

  66. Holmberg L, Garmo H, Grandstrand B et al. (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for Ductal Carcinoma in situ of the Breast. J Clin Oncol 26: 1247–1252

    Article  PubMed  Google Scholar 

  67. Fisher B, Dignam J, Wolmark N et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16: 441–452

    PubMed  CAS  Google Scholar 

  68. Viani GA, Stefano EJ, Afonso SL et al. (2007) Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2: 28

    Article  PubMed  Google Scholar 

  69. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2010) Overview of the randomized trial of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monog 41: 162–177

    Google Scholar 

  70. MacDonald HR, Silverstein MJ, Mabry H et al. (2005) Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 190: 521–525

    Article  PubMed  Google Scholar 

  71. Warren JL, Weaver DL, Bocklage T et al. (2005) The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS. Cancer 104: 1840–1848

    Article  PubMed  Google Scholar 

  72. Pinsky RW, Rebner M, Pierce LJ et al. (2007) Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detections, and stage of recurrence. Am J Roentgenol 1889: 140–144

    Article  Google Scholar 

  73. Tunon De Lara C, Lemanski C, Cohen-Solal-Le Nir C et al. (2010) Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk. Eur J Surg Oncol 36: 1165–1171

    Article  PubMed  CAS  Google Scholar 

  74. Tunon De Lara C, Andre G, MacGrogan G et al. (2011) Ductal carcinoma in situ of the Breast: influence of age on diagnostic, therapeutic and prognostic features. Retrospective study of 812 patients. Ann Surg Oncol 18: 1372–1379

    Article  PubMed  Google Scholar 

  75. Silverstein MJ, Buchanan C (2003) Ductal Carcinoma in situ: USC/Van Nuys prognostic index and the impact of margin status. The Breast 12: 457–471

    Article  PubMed  Google Scholar 

  76. Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27: 1615–1620

    Article  PubMed  Google Scholar 

  77. Monteau A, Sigal-Zafrani B, Kirova Y et al. (2009) Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexision or radiotherapy with increased dosage. Int J Rad Oncol Biol Phys 75: 1021–1028

    Article  Google Scholar 

  78. Solin L, Fourquet A, Vicini F et al. (2005) Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 41: 1715–1723

    Article  PubMed  Google Scholar 

  79. Sigal-Zafrani B, Lewis JS, Clough KB et al. (2004) Histological margin assessment for breast ductal carcinoma in situ: precision and implications. Mod Pathol 17: 81–88

    Article  PubMed  Google Scholar 

  80. Shamliyan T, Wang SY, Virnig BA, Tuttle TM, Kane RL (2010) Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ. J Natl Cancer Inst Monog 41: 121–129

    Article  Google Scholar 

  81. Silverstein MJ, Lagios MD (2007) Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. one size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation. J Surg Oncol 95: 605–609

    Article  PubMed  Google Scholar 

  82. Fisher B, Dignam J, Wolmark N et al. (2000) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353: 1993–2000

    Article  Google Scholar 

  83. Eng-Wong J, Costantino JP, Swain SM (2010) The impact of systemic therapy following ductal carcinoma in situ. J Natl Cancer Inst Monog 41: 200–203

    Article  Google Scholar 

  84. Yen TW, Hunt K, Mirza NO et al. (2004) Physician recommendations regarding Tamoxifen and patient utilisation of Tamoxifen after surgery for ductal carcinoma in situ. Cancer 100: 942–949

    Article  PubMed  CAS  Google Scholar 

  85. Claus EB, Stowe M, Carter D, Holford T (2003) The risk of contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. The Breast 12: 451–456

    Article  PubMed  Google Scholar 

  86. Omlin A, Amichetti M, Azria D et al. (2006) Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre retrospective study of the Rare Cancer Network. Lancet Oncol 8: 652–656

    Article  Google Scholar 

  87. Smith GL, Smith BD, Haffty BG (2006) Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 5: 1397–1403

    Article  Google Scholar 

  88. MacAusland SG, Hepel JT, Chong FK et al. (2007) An attempt to indipendently verify the utility of the Van Nuys prognostic index for ductal carcinoma in situ. Cancer 110: 2648–2653

    Article  PubMed  Google Scholar 

  89. Hwang ES (2010) The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy. J Natl Cancer Inst Monog 41: 197–199

    Article  Google Scholar 

  90. Kelley L, Silverstein M, Guerra L (2011) Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/ Van Nuys prognostic index Ann Surg Oncol 18: 459–462

    Article  PubMed  Google Scholar 

  91. Rashtian A, Iganej S, Liu IL, Natarajan S (2008) Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy. Int J Radiot Oncol Phys 72: 1016–1020

    Article  Google Scholar 

  92. Altinas S, Lambein K, Huizing MT et al. (2009) Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathological study. Breast J 15: 120–132

    Article  Google Scholar 

  93. Rudloff U, Jacks LM, Goldberg JI et al. (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28: 3762–3769

    Article  PubMed  Google Scholar 

Download references

Authors
  1. B. Cutuli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Cutuli, B. (2012). Le cancer canalaire in situ en 2011. Synthèse des nouvelles données de la littérature et des recommandations INCa-SFSPM. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_40

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0245-9_40

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0244-2

  • Online ISBN: 978-2-8178-0245-9

Publish with us

Policies and ethics

Search

Navigation